These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7481405)

  • 21. Magnetic resonance spectroscopy of the thalamus in patients with mesial temporal lobe epilepsy and hippocampal sclerosis.
    Fojtiková D; Brázdil M; Skoch A; Jírů F; Horký J; Marecek R; Mikl M; Krupa P
    Epileptic Disord; 2007 Dec; 9 Suppl 1():S59-67. PubMed ID: 18319202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A short-echo-time proton magnetic resonance spectroscopic imaging study of temporal lobe epilepsy.
    Simister RJ; Woermann FG; McLean MA; Bartlett PA; Barker GJ; Duncan JS
    Epilepsia; 2002 Sep; 43(9):1021-31. PubMed ID: 12199727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton magnetic resonance spectroscopy of temporal lobe white matter in patients with histologically proven hippocampal sclerosis.
    Meiners LC; van der Grond J; van Rijen PC; Springorum R; de Kort GA; Jansen GH
    J Magn Reson Imaging; 2000 Jan; 11(1):25-31. PubMed ID: 10676617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary observations of metabolic characterization of bilateral temporal epileptic focus, using proton magnetic resonance spectroscopy. Three cases.
    Giroud M; Walker P; Bernard D; Fayolle H; Beaurain J; Baudoin N; Brunotte F; Dumas R
    Neurol Res; 1994 Dec; 16(6):481-3. PubMed ID: 7708143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-acetyl-aspartate, total creatine, and myo-inositol in the epileptogenic human hippocampus.
    Petroff OA; Errante LD; Kim JH; Spencer DD
    Neurology; 2003 May; 60(10):1646-51. PubMed ID: 12771256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extent of preoperative abnormalities and focus lateralization predict postoperative normalization of contralateral 1H-magnetic resonance spectroscopy metabolite levels in patients with temporal lobe epilepsy.
    Lantz G; Seeck M; Lazeyras F
    AJNR Am J Neuroradiol; 2006 Sep; 27(8):1766-9. PubMed ID: 16971633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders.
    van der Knaap MS; van der Grond J; Luyten PR; den Hollander JA; Nauta JJ; Valk J
    Ann Neurol; 1992 Feb; 31(2):202-11. PubMed ID: 1575459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1H-MRS metabolite's ratios show temporal alternation in temporal lobe seizure: Comparison between interictal and postictal phases.
    Fadaie F; Mobarakeh NM; Fesharaki SS; Harirchian MH; Kharazi HH; Rad HS; Habibabadi JM
    Epilepsy Res; 2016 Dec; 128():158-162. PubMed ID: 27838503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic and electrophysiological alterations in subtypes of temporal lobe epilepsy: a combined proton magnetic resonance spectroscopic imaging and depth electrodes study.
    Guye M; Le Fur Y; Confort-Gouny S; Ranjeva JP; Bartolomei F; Régis J; Raybaud CA; Chauvel P; Cozzone PJ
    Epilepsia; 2002 Oct; 43(10):1197-209. PubMed ID: 12366736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging.
    Hugg JW; Laxer KD; Matson GB; Maudsley AA; Weiner MW
    Ann Neurol; 1993 Dec; 34(6):788-94. PubMed ID: 8250527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis.
    Renshaw PF; Yurgelun-Todd DA; Tohen M; Gruber S; Cohen BM
    Am J Psychiatry; 1995 Mar; 152(3):444-6. PubMed ID: 7864274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton magnetic resonance spectroscopy reveals medial temporal metabolic abnormalities in adolescents with history of preterm birth.
    Gimenez M; Soria-Pastor S; Junque C; Caldu X; Narberhaus A; Botet F; Bargallo N; Falcon C; Mercader JM
    Pediatr Res; 2008 Nov; 64(5):572-7. PubMed ID: 18596571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo.
    Duc CO; Trabesinger AH; Weber OM; Meier D; Walder M; Wieser HG; Boesiger P
    Magn Reson Imaging; 1998 Oct; 16(8):969-79. PubMed ID: 9814780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hippocampal N-acetyl aspartate levels do not mirror neuronal cell densities in creatine-supplemented epileptic rats.
    Vielhaber S; Kudin AP; Kudina TA; Stiller D; Scheich H; Schoenfeld A; Feistner H; Heinze HJ; Elger CE; Kunz WS
    Eur J Neurosci; 2003 Oct; 18(8):2292-300. PubMed ID: 14622190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial volume effects in volume-localized phased-array proton spectroscopy of the temporal lobe.
    Strauss WL; Tsuruda JS; Richards TL
    J Magn Reson Imaging; 1995; 5(4):433-6. PubMed ID: 7549206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applications of neural network analyses to in vivo 1H magnetic resonance spectroscopy of epilepsy patients.
    Bakken IJ; Axelson D; Kvistad KA; Brodtkorb E; Müller B; Aasly J; Gribbestad IS
    Epilepsy Res; 1999 Jul; 35(3):245-52. PubMed ID: 10413319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton MR spectroscopy in patients with seizure disorders.
    Breiter SN; Arroyo S; Mathews VP; Lesser RP; Bryan RN; Barker PB
    AJNR Am J Neuroradiol; 1994 Feb; 15(2):373-84. PubMed ID: 8192088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A subcortical network of dysfunction in TLE measured by magnetic resonance spectroscopy.
    Hetherington HP; Kuzniecky RI; Vives K; Devinsky O; Pacia S; Luciano D; Vasquez B; Haut S; Spencer DD; Pan JW
    Neurology; 2007 Dec; 69(24):2256-65. PubMed ID: 18071146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early life socioeconomic status, chronic physiological stress and hippocampal N-acetyl aspartate concentrations.
    McLean J; Krishnadas R; Batty GD; Burns H; Deans KA; Ford I; McConnachie A; McGinty A; McLean JS; Millar K; Sattar N; Shiels PG; Tannahill C; Velupillai YN; Packard CJ; Condon BR; Hadley DM; Cavanagh J
    Behav Brain Res; 2012 Dec; 235(2):225-30. PubMed ID: 22917526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study of hippocampal N-acetyl-aspartate in youth with treatment resistant major depression.
    Lefebvre D; Langevin LM; Jaworska N; Harris AD; Lebel RM; Jasaui Y; Kirton A; Wilkes TC; Sembo M; Swansburg R; MacMaster FP
    J Affect Disord; 2017 Jan; 207():110-113. PubMed ID: 27721183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.